Global EditionASIA 中文双语Français
China
Home / China / Latest

Sinopharm applies for vaccine market approval

chinadaily.com.cn | Updated: 2020-11-25 14:29
Share
Share - WeChat
A staff member displays a sample of the COVID-19 inactivated vaccine at a vaccine production plant of China National Pharmaceutical Group Co Ltd (Sinopharm) in Beijing, capital of China, April 10, 2020. [Photo/Xinhua]

Leading COVID-19 vaccine developer Sinopharm has submitted a market approval application to the top market regulator, according to media reports.

Photo
Exploring Tianjin's unique charm with China Daily's Yuanxi
Shanghai auto festival brings high-octane fun
Niche tourism sector gains healthy advantage in Shanghai
Ten photos from across China: April 19 - 25
Shenzhou XVIII astronauts enter space station
Launch of Shenzhou XVIII crewed spaceship a complete success
Latest
State Council News
Xi meets U.S. secretary of state
Exclusive
Posters: Health literacy rate up in 2023
Milestones of China's journey to space
Echoes of Chinese: Three adventures, one language
Newsmaker
Tibetan woman makes history, flies fighter jet
From audience to race driver, China's 1st F1 star Zhou Guanyu shines at home
Ten photos you don't wanna miss
Ten photos from across China: April 19 - 25
Special Coverage
National Security Education Day
2024 NPC & CPPCC National Committee sessions
Top
BACK TO THE TOP
English
中文
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
About China Daily
Advertise on Site
Contact Us
Job Offer
Expat Employment
FOLLOW US